eCORE
- Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation
- Global Health
Team
Group Leader
Antònia Agustí Escasany
Principal Investigator (PI)
Antònia Agustí Escasany
Researchers
Immaculada Danés Carreras, Mònica Sabaté Gallego, Montserrat Bosch Ferrer, Lina Camacho Arteaga, Carla Sans Pola, Eduard Diogène Fadini, Lourdes Vendrell Bosch, Eulàlia Pérez Esquirol, Elena Ballarin Alins, Francisco Javier Medel Rebollo, Ana Server Salva
PhD Students
Manuel Machado Duque, Emilie Anderssen Nordahl, Gustavo Molina Molina, Judit Riera Arnau, Lucia Bellas Fernández, Lina Leguizamo Martínez, Marta Merino Castelló, Gemma Puig Comas, Daniel Wang, Vanessa Prieto Martínez, Suyban Mata Ley
Selected Publications
Onken M, Lohse L, Coulm B, Beghin D, Richardson JL, Bermejo-Sánchez E, Aguilera C, Bosch M, Cassina M, Chouchana L, De Santis M, Duman MK, Gören MZ, Johnson D, Bera APJ, Kaplan YC, Kennedy D, Kwok S, Lacroix I, Lepelley M, Pistelli A, Schaefer C, Te Winkel B, Uysal N, Winterfeld U, Yakuwa N, Diav-Citrin O, Vial T, Dathe K.
Effects of maternal modafinil treatment on fetal development and neonatal growth parameters - a multicenter case series of the European Network of Teratology Information Services (ENTIS)
Acta Psychiatr Scand. 2024 Nov;150(5):372-384.
DOI: 10.1111/acps.13643.
IF: 5.3
Molina-Molina GJ, Garnica Velandia DR, Andrés-López B, Perales C, Marin-Asensio L, Jurgens Y, Esteso O, Escobar C, Vidal X, Vendrell L, Gómez-Ganda L, Rodríguez D, Montané E, Cardona V, Agustí A.
Delabelling beta-lactam allergy.
Front Pharmacol. 2024 Jun 27;15:1423719.
DOI: 10.3389/fphar.2024.1423719
IF: 4.4
Anderssen-Nordahl E, Fernández-Liz E, Sabaté Gallego M, Bosch Ferrer M, Sánchez-Arcilla Rosanas M, Cervera León M, Magrinyà JM, Barceló-Colomer ME.
The impact of a multidisciplinary team intervention on medication prescription in nursing homes in Catalonia.
Front Pharmacol. 2024 Sep 13;15:1445141.
DOI: 10.3389/fphar.2024.1445141.
IF: 4.4
Riera-Arnau J, Ballarin E, Llop R, Montane E, Hereu P, Vancells G, Padulles-Zamora N, Barriocanal AM, Cardona-Peitx G, Casasnovas C, Montoro JB, Nunez M, Santacana Juncosa E, Selva-O'Callaghan A, Solanich X, Sabate Gallego M
Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.
Front Pharmacol. 2024 Dec 16;15:1420682
DOI: 10.3389/fphar.2024.1420682.
IF: 4.4
Bellas L, Camacho-Arteaga L, Giner-Soriano M, Prats-Uribe A, Aguilera C, Vedia Urgell C, Agusti A
Women's health in focus: Real-world data on valproate prescriptions during pregnancy - a cohort study in Catalonia (Spain).
BMJ Open. 2024 Aug 12;14(8):e085167.
DOI: 10.1136/bmjopen-2024-085167.
IF: 2.4
Selected Projects
Genomics of COVID-19 vaccine-induced GBS, VITT/TTS and miocarditis/pericarditis
Principal Investigator: Xavier Martínez and Mònica Sabaté
Agency: US CDC Promotor: VAC4EU (GVDN)
Funding: 10,000$+3,000$+100$case+20$control from US CDC
Period: 2022-2025
A framework for the post-authorisation safety monitoring and evaluation of vaccines in EU. SAFETY-VAC (EMA/2020/46/TDA/18, Lot 5)
Principal Investigator: Carlos Durán
Agency: European Medicines Agency
Funding: 1,000,000 € for the whole project
Period: 2023-2024
Use of antiepileptics, and feasibility of studies on the association between maternal and paternal exposure to antiepileptics and risk of adverse pregnancy, neonatal and child outcome. ADEPT (EMA/2020/46/TDA/20, Lot 5)
Principal Investigator: Miriam Sturkenboom
Agency: European Medicines Agency
Funding: 750,000€ (VHIR 3,630€)
Period: 2024-2026
Comparative effectiveness and safety studies using the target trial emulation and estimand frameworks. TARGET EU (EMA/2020/46/TDA/19, Lot 5).
Principal Investigator: Olaf Klungel, Colider 1rst work-package Mònica Sabaté
Agency: European Medicines Agency
Funding: 998,000€ (VHIR: 49,500€)
Period: 2024-2026
Uso de fármacos en mujeres embarazadas y lactantes. Consecuencias en la salud de estas mujeres y en la de su descendencia.
Principal Investigator: Cristina Vèdia - Lina Camacho
Agency: PERIS- Departament de Salut, Generalitat de Catalunya SLT021/21/000068
Funding: All project 150,964,95 € (VHIR 4,500 €)
Period: 2022-2024
Selected Dissemination Activities
2a diada FARMACOVIGILANT
Place: Acadèmia de Ciències Mèdiques de Barcelona
Date: 01/01/1970
Brief: Several medical residents from the service comment on several cases of adverse drug reactions to the audience.
MORE INFO
16th Congress of EACPT 2024 – Rotterdam, June 8th-11h
Place: Rotterdam
Date: 06/08/2024
Brief: A research from our group commented on several scientific and other kind of activities developed during the year for the Young Clinical pharmacology group.
MORE INFO
Jornades doctorals 2024_Societat Catalana de Farmacologia
Place: Barcelona, Acadèmia de ciències Mèdiques
Date: 01/01/1970
Brief: A PhD research communicated the full results of one study of her PhD project.
MORE INFO
